摘要Hexavalent chromium Cr(Ⅵ),as a well-established carcinogen,contributes to tumorigenesis for many human cancers,especially respiratory and digestive tumors.However,the potential function and relevant mechanism of Cr(Ⅵ)on the initiation of esophageal carcinogenesis are largely unknown.Here,immortalized human esophageal epithelial cells(HEECs)were induced to be malignantly transformed cells,termed HEEC-Cr(Ⅵ)cells,via chronic exposure to Cr(Ⅵ),which simulates the progress of esophageal tumorigenesis.In vitro and in vivo experiments demonstrated that HEEC-Cr(Ⅵ)cells obtain the ability of anchorage-independent growth,greater proliferative capacity,cancer stem cell properties,and the capacity to form subcutaneous xenografts in BALB/c nude mice when compared to their parental cells,HEECs.Additionally,HEEC-Cr(Ⅵ)cells exhibited weakened cell motility and enhanced cell adhesion.Interestingly,HEECs with acute exposure to Cr(Ⅵ)failed to display those malignant phenotypes of HEEC-Cr(Ⅵ)cells,suggesting that Cr(Ⅵ)-induced malignant transformation,but not Cr(Ⅵ)itself,is the cause for the tumor characteristics of HEEC-Cr(Ⅵ)cells.Mechanistically,chronic exposure to Cr(Ⅵ)induced abnormal activation of Notch signaling,which is crucial to maintaining the capacity for malignant proliferation and stemness of HEEC-Cr(Ⅵ)cells.As expected,N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester(DAPT),an inhibitor for the Notch pathway,drastically attenuated cancerous phenotypes of HEEC-Cr(Ⅵ)cells.In conclusion,our study clarified the molecular mechanism underlying Cr(Ⅵ)-induced esophageal tumorigenesis,which provides novel insights for further basic research and clinical therapeutic strategies about Cr(Ⅵ)-associated esophageal cancer.